Prne
August 23rd, 2009
DOYLESTOWN, Pennsylvania -
- Novel Self-Expanding Platform for Treatment of Coronary Artery Disease Receives European Regulatory Clearance
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
The novel vProtect(TM) Luminal Shield has the potential to change the way interventional cardiologists treat arterial plaques. The vProtect(TM) Luminal Shield is designed to minimize arterial injury and its consequences, allowing the vessel to regain and maintain healthy physiological function. The device is a low radial force, thin-strut, self-expanding nitinol mesh, or “Shield” that is designed specifically for softer plaques.
“We are very pleased with the performance of the Shield in our clinical study program,” said principal investigator Juan F. Granada, MD, Medical Director, Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, New York, NY. “We achieved excellent technical results. In this clinical series there were no peri-procedural MACE events and we achieved device delivery success in all the cases. The Shield continues to demonstrate a very favorable efficacy profile in all cases evaluated to date.”
“This CE Mark approval represents a significant milestone for the company and reflects the positive results of our clinical studies to date,” noted Patricia Scheller, CEO of Prescient Medical. “It also marks the beginning of an exciting broad-based clinical program to assess the performance of the vProtect(TM) Luminal Shield in more specific patient groups,” she concluded.
About Prescient Medical, Inc.
Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The company is the recipient of the 2009 Frost and Sullivan Award for Product Innovation of the Year Award for vProtect(TM) Luminal Shield. For more information about Prescient Medical and its products, please visit our website at www.prescientmedical.com.
Source: Prescient Medical, Inc.
Ilana Odess of Prescient Medical, Inc., +1-917-941-9990, iodess at prescientmedical.com
Filed under Business, European Government, Government and Policy, Health, Health Care / Hospitals, Medical Equipment, New Products / Services, Pharmaceuticals | Tags: Doylestown, Inc., Pennsylvania, Prescient Medical, Russia, Western Europe | Comment Below
Related Press Releases Occlutech Receives Positive Ruling in German Proceeding Initiated by AGA MedicalSeptember 22nd, 2009 JENA, Germany - Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders. The district court of Frankfurt reversed its earlier decision that was based on a request by AGA Medical, relying only on information provided by AGA Medical. Retail Decisions Announced as Finalist for Orange National Business 'Best use of Technology in Business' AwardSeptember 2nd, 2009 LONDON - Retail Decisions (ReD), a payment card issuer and world leader in payment card fraud prevention, is announced today as a finalist in The National Business Awards for The Orange Best Use of Technology in Business Accolade. Retail Decisions is one of 10 finalists. Prescient Medical Inc. Featured on FOX Business NetworkAugust 30th, 2009 DOYLESTOWN, Pennsylvania -
Prescient Medical Inc. announced that CEO Patricia Scheller, appeared on FOX Business Network (FBN) to discuss the company's groundbreaking products and recent achievement of CE Mark approval for their vProtect(TM) Luminal Shield Stent System. Watermeadow Medical Wins Medical Education Consultancy of the Year AwardJuly 12th, 2009 OXFORD, England - International medical communications company, Watermeadow Medical was named Medical Education Consultancy of the Year at the Communique Awards in London on Thursday night. This highly contested award is judged by an independent panel of communications experts, who assess excellence and innovation in the delivery of medical education for healthcare clients, along with business strategy, client retention, client satisfaction, financial performance, and staff development. Unisense FertiliTech A/S Receives CE Mark of Approval for EmbryoScope(TM) Embryo Monitoring SystemJuly 6th, 2009 AARHUS, Denmark - Unisense FertiliTech A/S ( www.fertilitech.com) announces that the EmbryoScope(TM) Embryo Monitoring System and EmbryoSlide(TM) tray have received CE approval as class IIa medical devices for use in IVF. Unisense Fertilitech A/S also received the DS/EN ISO13485:2003 and AC:2007 quality system certificate for production, installation and servicing of IVF incubators and related accessories
(Photo: www.newscom.com/cgi-bin/prnh/20090706/353010 )
Francesca Bahr, sales manager at Unisense FertiliTech A/S says "the CE mark will allow us to market the instrument to Assisted Reproduction clinics across Europe, with the goal of improving embryo assessment and to facilitate the goal of elective single embryo transfer". Vitria to Host Webinar on Operational IntelligenceJune 24th, 2009 LONDON -
- Ventana Research CEO Mark Smith to Discuss How OI Reduces Time to Action
Vitria Technology, Inc., today announced open registration for a webinar July 2nd , titled "Reduce Your Time to Action with Operational Intelligence." Mark Smith, CEO & EVP of Research with Ventana Research, a leading benchmark research and advisory services firm, will introduce Operational Intelligence (OI) and discuss how it can enhance operational activities, processes and systems to provide organisations with the visibility and insight required to make decisions based on real time information. In today's economic climate, gaining competitive edge is critical for retaining customers and improving profit margins. Prescient Selects Eagle's Investment Management Suite to Support Global Growth ObjectivesJune 23rd, 2009 JOHANNESBURG -
- South African Investment Manager to migrate back office processes to hosted offering
Eagle Investment Systems LLC, a leading provider of financial services technology and a subsidiary of The Bank of New York Mellon, has been selected by Prescient to deliver its integrated investment management suite via its application service provider (ASP), Eagle ACCESS(SM). Prescient, with R60 billion under management in South Africa, selected the Eagle suite to streamline its growing local and global operations. Eucomed Survey Shows European Medical Technology Industry is Weathering the Storm but Bracing Itself for Tough TimesMay 18th, 2009 BRUSSELS - Companies "Taking no Chances" - Hospitals Struggling and Price Pressure Increasing
The global economic crisis and recession have shaken many governments and industries. However, a recent survey conducted by Eucomed of 100 top executives at medical technology manufacturers across Europe defies this trend with only 20% of respondents noticing a significant negative impact on their business. Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) InhibitorMay 12th, 2009 NERVIANO, Italy - The FDA has approved an Investigational New Drug (IND) application by Nerviano Medical Sciences to begin a phase I clinical study with its selective PLK-1 small molecule inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for the proliferation of cancer cells. NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) DeviceApril 20th, 2009 NESHER, Israel - Portable Solution for Wound Healing Using Low Frequency, Low Intensity Ultrasound
NanoVibronix, a medical device company specializing in applications that implement surface ultrasound waves, announced that its novel device has received CE approval in Europe for additional claims of wound healing. PainShield is the first hands-free, patch-based device that uses surface ultrasound waves for therapeutic treatment of wounds.
Related News Martin Love to quit cricketFebruary 25th, 2009 SYDNEY - New Zealand batsman Martin Love, whose last Test innings was a hundred, has decided to hang his boots. Queensland's greatest run scorer said he had no regrets, despite being dropped from the 2003 Test side after scoring an unbeaten ton. Aussie Martin Love to retire from cricketFebruary 25th, 2009 SYDNEY - Australian Martin Love, who scored a hundred in his last Test innings, has decided to call it a day. Queensland's biggest run scorer said he had no regrets, despite being dropped from the 2003 Test side after scoring an unbeaten ton. Warner hopes to return for Aussie one-day series in South AfricaFebruary 9th, 2009 SYDNEY - After being dropped from the national one-day squad, Australian sensation David Warner is hoping to return for the five-match ODI series in South Africa. Warner, who will play for Delhi Daredevils in the IPL, is the only Australian since 1877 to make his international debut before playing a first-class match. Democratic Sen. Schumer criticizes Obama administration position on media shieldOctober 1st, 2009 Sponsor of media shield criticizes administrationWASHINGTON — A key Senate sponsor of a bill to protect reporters' sources in federal court said Thursday the Obama administration has unexpectedly tried to weaken the protections. Supporters of the so-called media shield bill must now decide whether to proceed without counting on administration support. US, Russia admit differences over missile shieldApril 1st, 2009 LONDON - Russian President Dmitry Medvedev and his US counterpart Barack Obama Wednesday admitted that there were still differences between the two nations over the issue of US-proposed missile shield in Central Europe. 'While acknowledging that differences remain over the purposes of deployment of missile defence assets in Europe, we discussed new possibilities for mutual international cooperation in the field of missile defence,' the two leaders said in a joint statement after their meeting in London. Missile defence shield: India to test interceptor FridayMarch 6th, 2009 NEW DELHI -India will Friday test launch its indigenous interceptor missile that will destroy an incoming ballistic 'enemy' missile at an altitude of 80 km and will provide defence against Pakistani and Chinese missiles, an official said. 'All the preparations have been made and all the scientists are working to make the test successful,' a Defence Research and Development Organisation (DRDO) official said. Northrop Grumman receives contract modification from NavyJune 23rd, 2009 Northrop Grumman receives contract modificationNEW YORK — Northrop Grumman Shipbuilding Inc., a unit of Northrop Grumman Corp. is being awarded a $213.8 million modification to a previously awarded Navy contract, the U.S. Ga. doctor receives package with 36 pounds of pot wrapped in cellophaneMay 8th, 2009 Doctor receives package with 36 pounds of potSTOCKBRIDGE, Ga. — Police are trying to determine who sent a Stockbridge physician a large quantity of marijuana. Seinfeld, Rock and Rashad among stars to honor Bill Cosby with Mark Twain humor prizeAugust 20th, 2009 Seinfeld to salute Cosby with top humor prizeWASHINGTON — The comedian who kept NBC viewers entertained on Thursday nights well after "The Cosby Show" was gone will salute Bill Cosby when he receives the nation's top humor prize. Jerry Seinfeld will honor Cosby on Oct. Medvedev hopes to discuss missile shield with ObamaMarch 2nd, 2009 MOSCOW - Russian President Dmitry Medvedev said Sunday he hoped to discuss US plans to deploy a missile shield system in Central Europe with his American counterpart Barack Obama when they will meet in April during the G20 summit in London. In an interview with the Spanish media, Medvedev said he hoped the new US administration would display a more creative approach to this issue than the previous George Bush administration.
|
|